Related Experiment Video
Updated: May 13, 2026
14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression
M C C Sachweh1, C J Drummond, M Higgins
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Cell Death & Disease
|March 9, 2013
Summary
Nutlin-3 and trichostatin A (TSA) combination did not increase p21 levels as expected. P53 activation by Nutlin-3 interfered with TSA's ability to boost p21 and other p53-dependent gene expression.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Nutlin-3 activates p53 by inhibiting MDM2 interaction.
- Trichostatin A (TSA) is a potent histone deacetylase (HDAC) inhibitor.
- Both compounds can increase the cell cycle inhibitor p21 levels.
Purpose of the Study:
- To investigate the combined effect of Nutlin-3 and TSA on p21 levels.
- To understand the interaction between p53 activation and HDAC inhibition in regulating gene expression.
Main Methods:
- Short-term exposure of cells to Nutlin-3 and TSA.
- Analysis of p21(cip1/waf1) expression levels.
- Measurement of p53-dependent mRNAs, including P21 and hdm2.
Main Results:
- Combined Nutlin-3 and TSA did not show an additive effect on p21 expression.
- p53 activation by Nutlin-3 inhibited TSA's ability to increase p21 levels.
- TSA suppressed Nutlin-3-induced expression of p53-dependent mRNAs, with a less pronounced effect on hdm2 compared to P21.
Conclusions:
- p53 activation and HDAC inhibition have incompatible effects on p21 regulation.
- Findings suggest a complex interplay between these pathways with implications for cancer therapy and cell reprogramming.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.